Clinical Trial: Phase 3 Efficacy and Durability of Ampreloxetine for the Treatment of Symptomatic nOH in Participants With Multiple System Atrophy
Study Status: Completed
Recruit Status: RECRUITING
Condition: Symptomatic Neurogenic Orthostatic Hypotension
Study Type: INTERVENTIONAL
Official Title: A Phase 3, Multi-center, Randomized Withdrawal and Long Term Extension Study of Ampreloxetine for the Treatment of Symptomatic Neurogenic Orthostatic Hypotension in Participants With Multiple System A
Brief Summary:
This is a Phase 3, multi-center, randomized withdrawal study to evaluate the efficacy and durability of ampreloxetine in participants with MSA and symptomatic nOH after 20 weeks of treatment.This study includes 4 periods: Screening, open label, randomized withdrawal, and long-term treatment extension (LTE).
Read more